GSK
Europe’s magnificent 11 stocks – the Granolas
Continent’s top firms drove most of European equity gains last year
Global stocks slip as US inflation data spooks investors
Euronext Dublin finished the day down 0.3% as it was dragged lower by homebuilders and hotels group Dalata
GSK sees strong growth following Haleon split and vaccine drive
British drug maker’s first annual earnings report after spinning off Haleon in July 2022
Compensation scheme for medical trial victims at mother and baby homes to open, but GSK won’t contribute
Pharma giant GSK, whose predecessor companies profited from the trials, has so far resisted calls to contribute
Drugmaker GSK sells €1bn stake in former consumer health unit Haleon
British medicines group and US rival Pfizer have both committed to selling down stakes over time to fund core pharma operations
Have consumer goods price rises peaked?
Shoppers choosing to buy less has spooked large groups but costs unlikely to drop even as inflation moderates
Unilever says UK inflation has peaked as sales growth accelerates
Maker of Marmite and Magnums latest to signal easing of inflationary pressures
European shares dip on interest rate worries
Bank shares edge backwards while Glanbia and Irish Continental rise
GSK sales fall after demand for Covid treatment plummets
Drugmaker’s Xevudy fails to tackle most prevalent variants of coronavirus, say US regulators
Burberry finds new CFO at supercar manufacturer McLaren
Kate Ferry to replace Julie Brown who heads to GSK
Justine McCarthy: Until GSK compensates mother-and-baby-home children, don’t buy its medicines
Drug giant rang up worldwide sales of more than £29 billion last year. Its refusal to contribute a cent to State’s redress scheme is inexcusable
Pfizer’s RSV vaccine wins US panel’s backing for safety in older people
Questions remain about hospitalisation and side effects but drugmaker stays step ahead of British group GSK which faces similar panel
Left behind - survivors subjected to medical experiments in mother and baby homes
In the News podcast with Bernice Harrison
Vaccine trials: Reparations and consent not only points of conflict between Government and GSK
Clinical trials carried out between 1934 and 1973 centred on childhood vaccines and infant milk products
GSK repeatedly rejected State demands to pay reparations for vaccine trials on children
O’Gorman urged drug firm to accept corporate responsibility for way tests were carried out on mother-and-baby home children
GSK offers upbeat outlook as demand for vaccines fuels profit
UK drugmaker counting on several new vaccines, including one against RSV, to power growth in 2023
GSK on hunt for biotechs ‘hiding in plain sight’ to boost its drug pipeline
Chief commercial officer Luke Miels looking at targets, especially in cancer therapies, worth up to $2.5bn
Vaccine makers face revenue slump as demand falls for Covid-19 jabs
Pharmaceutical companies hunt for new revenue streams as pandemic becomes endemic
GSK spin-off Haleon slips 6% on market debut
Rump business will focus solely on vaccines and prescription medications
Pfizer Covid vaccines safe and effective for small children, FDA review finds
Sanofi says trials point to potential of its vaccine booster candidate against main variants of concern
Britain’s GSK to buy Affinivax for up to €3.1bn in vaccines push
Company is planning to separate its consumer unit
Markets in positive territory on economic hopes for China and the US
Iseq in Dublin closes the session up 1.3%
European shares close flat on weak Chinese economic information
Building and travel stocks struggle on Iseq
Global shares advance as investors go bargain hunting
Twitter stock tanks after Elon Musk puts $44bn deal on hold, but Tesla stock rises
Iseq lags slightly as European markets recover following Monday’s battering
Bargain-hunters enter market after sell-off on economic worries
European shares drop on disappointing earnings and Fed fears
Iseq down 0.5% as travel and leisure names weaken
GSK beats forecasts on back of Covid and shingles treatments
British drugmaker confirms guidance for year in which it will spin-off its consumer goods division
GlaxoSmithKline workers in UK vote to strike over pay rise
Strike backed by 86% of those balloted on below inflation pay offer would be first for top drugmaker
‘Game-changing’ Covid antiviral to be available in hospitals next week
Only inpatients will have access to Paxlovid; sotrovimab deemed ineffective against BA.2
Ukraine uncertainty keeps a lid on European shares but US markets rebound
Tech stocks keep the Nasdaq riding high
Interim examiner appointed to commercial fit-out company Sonica
Firm has been hit by Covid-19 restrictions and disputed payment in Germany
A round-up of popular courses in universities around the country
We list the top five courses and focus on a sample course from each college featured
European shares sink as geopolitical headwinds leave investors wary
Stocks have dropped almost 2% this week amid rising Russia-Ukraine tensions
Merck struggles to win European approval for Covid antiviral pill
Limited efficacy means it is increasingly seen as a therapy for those who cannot take rival medications
Unilever warns of high inflation impact on profits
Company says it will take two years to return to 2021 profitability level
GSK profits fall but plan remains to sell off consumer healthcare arm
Pharmaceuticals giant says profits fell by a fifth last year
Unilever investors want split or change amid rumbling discontent
Fallout from failed GSK unit bid dogs board as group prepares for results presentation
Sanofi buoyed by blockbuster eczema drug Dupixent
Pharmaceutical manufacturer to focus on cancer and immunology
New Covid-19 treatment drug available for use in Ireland
Government agrees supply deal with GSK for injectable drug sotrovimab
Unilever to cut 1,500 management jobs in overhaul
Group to organise its business into five new divisions in move to ease investor concerns
Activist investor provides twist in Unilever soap opera
Nelson Peltz has previously taken stake in rival consumer goods group Procter & Gamble
After its ‘near-death experience’, where does Unilever go from here?
Joe Brennan: Behemoth has been struggling to grow its sales at same pace as rivals
Travel stocks lead European shares higher as airlines soar
Ryanair advances as oil stocks come off near two-year high
Unilever chief under pressure after company walks away from GSK deal
Investor dissent forces company to drop bid for GlaxoSmothKline’s consumer products unit
Luxury goods, mining gains help European shares regain lost ground
Flutter the best performers in Dublin as Davy reiterates ‘outperform’ recommendation
European markets see-saw on corporate news while Wall Street closes for holiday
Irish shares static as activity remains subdued after Christmas
Unilever defends €60bn bid for GSK consumer health unit
Analysts negative on potential deal’s impact on debt and what it indicates about management thinking
Department defends €90m deal for antiviral drugs to treat Covid-19
Cost of deal is three times annual budget usually in place for new drugs in Republic
Vaccinated people coming to Ireland will not need negative Covid test from midnight
Cabinet approves deal for €90m worth of anti-viral drugs to help fight coronavirus
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices